Articles

Monoclonal antibodies (mAbs) form an important therapeutic agent for the treatment of several diseases.

It is estimated that new drugs take an average of 8–10 years to hit the shelves, costing around $ 1 billion

In today’s world, biotechnology has become one of the most important industries, as it deals with the important area of human healthcare.

With the advances in science and medicine, the fundamental approach towards diagnosis and treatment of various diseases has improved significantly over the years.

Light scattering is a powerful tool for the characterization of biopharmaceutical products.

Advances in cell replacement therapy and regenerative medicine are increasingly becoming popular as research explores their superior potential and high versatility.

The biopharmaceutical industry’s prospects in 2022 and beyond continue to drive manufacturers toward more productive and versatile bioprocessing solutions.

Biopharmaceuticals such as monoclonal antibodies and Fc-fusion proteins have become critically important in the treatment of a range of life-threatening diseases from cancer,

Monoclonal antibodies (mAbs) form an important therapeutic agent for the treatment of several diseases.

Accelerated development of novel therapeutics in an increasingly competitive and closely regulated scenario requires the use of progressive,

Process Analytical Technology (PAT) is a method for designing, analyzing, and controlling the pharmaceutical manufacturing process through the measurement of Critical Process Parameters (CPP)